UCL RESEARCH DEPARTMENT OF EPIDEMIOLOGY AND PUBLIC HEALTH

2012

• Mennini FS, Baio G, Montagano G, Cauzillo G, Locuratolo F, Becce G, Gitto L, Marcellusi A, Zweifel P, Capone A, Favato G (2012). Governance of preventive Health Intervention and On time Verification of its Efficiency: the GIOVE Study.. BMJ Open, 2(2), e000736 - . doi:10.1136/bmjopen-2011-000736
• Brentnall AR, Duffy SW, Baio G, Raine R (2012). Strategy for power calculation for interactions: application to a trial of interventions to improve uptake of bowel cancer screening.. Contemp Clin Trials, 33(1), 213 - 217. doi:10.1016/j.cct.2011.09.021

2011

• Corrao G, Scotti L, Zambon A, Baio G, Nicotra F, Conti V, Capri S, Tragni E, Merlino L, Catapano AL, Mancia G (2011). Cost-effectiveness of enhancing adherence to therapy with statins in the setting of primary cardiovascular prevention. Evidence from an empirical approach based on administrative databases.. Atherosclerosis, 217(2), 479 - 485. doi:10.1016/j.atherosclerosis.2011.04.014
• von Wagner C, Baio G, Raine R, Snowball J, Morris S, Atkin W, Obichere A, Handley G, Logan RF, Rainbow S, Smith S, Halloran S, Wardle J (2011). Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England. INT J EPIDEMIOL, 40(3), 712 - 718. doi:10.1093/ije/dyr008
• Baio G, Dawid AP (2011). Probabilistic Sensitivity Analysis in Health Economics. Statistical Methods in Medical Research, , - . doi:10.1177/0962280211419832
• Mennini FS, Baio G, Capone A, Marcellusi A, Favato G, Costa S, Garganese G, Picardo M, Drummond M, Jonsson B, Scambia G, Zweifel P (2011). BAYESIAN MODELLING ASSESSING THE EFFECTIVENESS OF A VACCINATION STRATEGY TO PREVENT HPV-RELATED DISEASES: THE BEST STUDY. VALUE IN HEALTH, 14(3), A165 - A165.
• Baio G, Barbagallo M, D'Avola G, Di Luccio A, Di Tanna GL, Falaschi P, Iolascon G, Malavolta N, Robbiati F, Ulivieri FM (2011). Improving adherence in osteoporosis: a new management algorithm for the patient with osteoporosis.. Expert Opin Pharmacother, 12(2), 257 - 268. doi:10.1517/14656566.2011.537259
• Baio G, Blangiardo GC, Blangiardo M (2011). Centre Sampling Technique in Foreign Migration Surveys: A Methodological Note. J OFF STAT, 27(3), 451 - 465.
• Osborn DP, Baio G, Walters K, Petersen I, Limburg H, Raine R, Nazareth I (2011). Inequalities in the provision of cardiovascular screening to people with severe mental illnesses in primary care: cohort study in the United Kingdom THIN Primary Care Database 2000-2007.. Schizophr Res, 129(2-3), 104 - 110. doi:10.1016/j.schres.2011.04.003

2010

• Baio G, Russo P (2010). A decision-theoretic framework for the application of cost-effectiveness analysis in regulatory processes | Un modello di analisi del valore dell'informazione per la valutazione di costo-efficacia nell'ambito del processo regolatorio. PharmacoEconomics - Italian Research Articles, 12(1), 5 - 16.
• Baio G (2010). Metodi statistici per la valutazione economica in sanità [Statistical methods for health economic evaluation, in Italian].
• Baio G, Blangiardo M (2010). Bayesian hierarchical model for the prediction of football results. Journal of Applied Statistics, 37(2), 253 - 264.

2009

• Baio G, Russo P (2009). A decision-theoretic framework for the application of cost-effectiveness analysis in regulatory processes.. Pharmacoeconomics, 27(8), 645 - 655. doi:10.2165/11310250-000000000-00000
• Avillach P, Mougin F, Joubert M, Thiessard F, Pariente A, Dufour JC, Trifirò G, Polimeni G, Catania MA, Giaquinto C, Mazzaglia G, Baio G, Herings R, Gini R, Hippisley-Cox J, Molokhia M, Pedersen L, Fourrier-Réglat A, Sturkenboom M, Fieschi M (2009). A semantic approach for the homogeneous identification of events in eight patient databases: a contribution to the European eu-ADR project.. Stud Health Technol Inform, 150, 190 - 194.
• Baio G, Di Tanna GL, Integlia D, Pammolli F (2009). HEALTH ECONOMIC EVALUATION OF THE TREATMENT OF OSTEOPOROSIS IN FIVE ITALIAN REGIONS. VALUE HEALTH, 12(7), A441 - A441.

2008

• Baio G, Dawid AP (2008). Probabilistic Sensitivity Analysis in Health Economics.
• Zambon A, Baio G, Mazzaglia G, Merlino L, Corrao G (2008). Discontinuity and failures of therapy with bisphosphonates: joint assessment of predictors with multi-state models.. Pharmacoepidemiol Drug Saf, 17(3), 260 - 269. doi:10.1002/pds.1530
• Blangiardo M, Baio G, Blangiardo GC (2008). Bayesian Latent Class Model to Measure Social Integration of Immigrants in Italy.

2007

• Baio G, Blangiardo M (2007). An Introduction to Bayesian Modelling for Social Sciences. In Osborne J (Ed.), Best Practice in Quantitative Methods (pp. - ). : SAGE Publisher.
• Schachter AD, Ramoni MF, Baio G, Roberts TG, Finkelstein SN (2007). Economic evaluation of a Bayesian model to predict late-phase success of new chemical entities.. Value Health, 10(5), 377 - 385. doi:10.1111/j.1524-4733.2007.00191.x
• Baio G, Corradi F (2007). Handling manipulated evidence.. Forensic Sci Int, 169(2-3), 181 - 187. doi:10.1016/j.forsciint.2006.08.017

2006

• Baio G, Pammolli F, Baldo V, Trivello R (2006). Object Oriented Influence Diagram for Cost Effectiveness Analysis of Influenza Vaccination in Italian Elderly Population.. Expert Review of Pharmacoeconomics and Outcomes Research, 6(3), 293 - 302.

2005

• Merito M, Bonaccorsi A, Pammolli F, Riccaboni M, Baio G, Arici C, Monforte AD, Pezzotti P, Corsini D, Tramarin A, Cauda R, Colangeli V, Pastore G, I.CO.N.A. Study Group (2005). Economic evaluation of HIV treatments: the I.CO.N.A. cohort study.. Health Policy, 74(3), 304 - 313. doi:10.1016/j.healthpol.2005.01.016

2004

• Baio G, Pammolli F, Baldo V, Trivello R (2004). The economic evaluation of influenza vaccination in the elderly population: A model based on Bayesian Networks. VALUE HEALTH, 7(3), 359 - 359.

2003

• Russo P, Capone A, Attanasio E, Baio G, Di Martino M, Degli Esposti L, Marchetta F, Buda S, Degli Esposti E, Caprino L (2003). Pharmacoutilization and costs of osteoarthritis: changes induced by the introduction of a cyclooxygenase-2 inhibitor into clinical practice.. Rheumatology (Oxford), 42(7), 879 - 887. doi:10.1093/rheumatology/keg242
• Baio G, Esposti LD, Esposti ED, Saragoni S, Capone A, Russo P, Pammolli F (2003). Bayesian cost-effectiveness analysis based on the persistence with antihypertensive treatment.. Expert Rev Pharmacoecon Outcomes Res, 3(3), 227 - 236. doi:10.1586/14737167.3.3.227

2002

• Esposti LD, Baio GL, Valpiani G, Buda S, Sturani A, Esposti ED (2002). Cost allocation in antihypertensive drug therapies. Expert Review of Pharmacoeconomics and Outcomes Research, 2(5), 419 - 426.
• Degli Esposti E, Sturani A, Di Martino M, Falasca P, Novi MV, Baio G, Buda S, Volpe M (2002). Long-term persistence with antihypertensive drugs in new patients.. J Hum Hypertens, 16(6), 439 - 444. doi:10.1038/sj.jhh.1001418
• Baio G, Degli Esposti L, Saragoni S, Degli Esposti E, Capone A, Pammolli F (2002). Persistence with anti hypertensive drug treatment: An evaluation based on a Bayesian cost-effectiveness approach. VALUE HEALTH, 5(6), 488 - 488.
• Russo P, Capone A, Baio G, Di Martino M, Degli Esposti L, Buda S, Degli Esposti E, Caprino L (2002). [Evaluation model of the effect of Rofecoxib on the co-prescription of gastroprotective agents observed during the treatment of osteoarthritis].. Reumatismo, 54(4), 331 - 339.
• Degli Esposti L, Valpiani G, Baio G (2002). Valutare l’efficacia degli interventi in sanità [Evaluating effectiveness in health, in Italian].
• Russo P, Capone A, Baio G, Di Martino M, Degli Esposti L, Buda S, Degli Esposti E, Caprinol L (2002). Evaluation model of the effect of rofecoxib on the co-prescription of gastroprotective agents observed during the treatment of ostheoarthritis | Modello valutativo dell'effetto sulla co-prescrizione di gastroprotettori osservato durante il trattamento dell'artrosi con rofecoxib. Reumatismo, 54(4), 331 - 339.
• Degli Esposti L, Degli Esposti E, Valpiani G, Di Martino M, Saragoni S, Buda S, Baio G, Capone A, Sturani A (2002). A retrospective, population-based analysis of persistence with antihypertensive drug therapy in primary care practice in Italy.. Clin Ther, 24(8), 1347 - 1357.

2001

• Russo P, Attanasio E, Baio G, Degli Esposti L, Buda S, Degli Esposti E, Caprino L (2001). An economic evaluation of rofecoxib versus NSAIDs in osteoarthritis | Una prima valutazione economica dell'impiego di rofecoxib versus FANS convenzionali nell'artrosi. PharmacoEconomics - Italian Research Articles, 3(2), 81 - 89.